AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16436011 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided to control subjects.
Number of subjects: 116
Study 10741150 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 0
Study 10741150 — intervention group
Group type: EXPERIMENTAL
Intervention: Purged HSCT
Number of subjects: 0
Study 10741150 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose therapy with HSCT
Number of subjects: 0
Study 9140122 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 200
Study 9140122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 9140122 — intervention group
Group type: EXPERIMENTAL
Intervention: Single observer reading
Number of subjects: 200
Study 8399609 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin
Number of subjects: 46
Study 8399609 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal ciprofloxacin (ip)
Number of subjects: 46
Study 3298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0
Study 3298402 — intervention group
Group type: EXPERIMENTAL
Intervention: Mephobarbital
Number of subjects: 0
Study 3298402 — intervention group
Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 0
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (refractory AML, <60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (refractory AML, <60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (refractory AML, >60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (refractory AML, >60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (relapsed AML, <60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (relapsed AML, <60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (relapsed AML, >60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (relapsed AML, >60 years)
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (refractory patients achieving CR)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (refractory patients achieving CR)
Number of subjects: 195
Study 3162515 — intervention group
Group type: EXPERIMENTAL
Intervention: HiDAC/ASNase (relapsed patients in CR)
Number of subjects: 195
Study 3162515 — intervention group
Group type: COMPARATOR
Intervention: HiDAC (relapsed patients in CR)
Number of subjects: 195
Study 31185157 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide
Number of subjects: 3183
Study 31185157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3183
Study 28844307 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate induction protocol (blood clot induction at first appointment)
Number of subjects: 25
Study 28844307 — intervention group
Group type: COMPARATOR
Intervention: Delayed induction protocol (calcium hydroxide as intracanal medication following AAE guidelines)
Number of subjects: 25
Study 25589599 — intervention group
Group type: EXPERIMENTAL
Intervention: Suggestive memory-retrieval techniques
Number of subjects: 0
Study 23329406 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% oxygen (GI)
Number of subjects: 20
Study 23329406 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen (GII)
Number of subjects: 20
Study 21715522 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet injection of insulin aspart (0.2 units/kg body wt)
Number of subjects: 18
Study 21715522 — intervention group
Group type: COMPARATOR
Intervention: Conventional pen injection of insulin aspart (0.2 units/kg body wt)
Number of subjects: 18
Study 19268914 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 10
Study 19268914 — intervention group
Group type: COMPARATOR
Intervention: Sham tryptophan depletion (STD, control)
Number of subjects: 10
Study 19268914 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ATD and STD
Number of subjects: 10
Study 17008339 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) - arm test (8 items)
Number of subjects: 396
Study 17008339 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) - hand test (9 items)
Number of subjects: 396
Study 17008339 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) - item level
Number of subjects: 396
Study 15454021 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse with oral hygiene instruction (OHI)
Number of subjects: 48
Study 15454021 — intervention group
Group type: COMPARATOR
Intervention: Normal saline mouthrinse with no oral hygiene instruction (OHI)
Number of subjects: 48
Study 15454021 — intervention group
Group type: COMPARATOR
Intervention: Normal saline mouthrinse with oral hygiene instruction (OHI)
Number of subjects: 48
Study 11385058 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable burger and fruit drink
Number of subjects: 22
Study 11385058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 10332346 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthrinse intervention; details on dosage and duration not available.
Number of subjects: 5
Study 8388007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (1%) administered four times daily
Number of subjects: 104
Study 8388007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 3440393 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial ileal bypass (PIB) surgery
Number of subjects: 838
Study 3440393 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 838
Study 29603219 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 130
Study 29603219 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-centered therapy (CCT)
Number of subjects: 130
Study 29603219 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 130
Study 29603219 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-task ratings
Number of subjects: 130
Study 28927227 — intervention group
Group type: EXPERIMENTAL
Intervention: Surotomycin 250 mg twice daily
Number of subjects: 26
Study 28927227 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin 125 mg four times daily
Number of subjects: 26
Study 28927227 — intervention group
Group type: EXPERIMENTAL
Intervention: Surotomycin 125 mg twice daily
Number of subjects: 26
Study 28927227 — intervention group
Group type: EXPERIMENTAL
Intervention: Surotomycin
Number of subjects: 26
Study 26182759 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% glycine
Number of subjects: 170
Study 26182759 — intervention group
Group type: COMPARATOR
Intervention: Sterile distilled water
Number of subjects: 170
Study 23108780 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SrRan)
Number of subjects: 10
Study 23108780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 20577144 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 30
Study 20577144 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 30
Study 20577144 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 30
Study 18335728 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% Hydrogen Peroxide (HP)
Number of subjects: 40
Study 18335728 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP plus Halogen Curing Light XL 3000 (3M/ESPE)
Number of subjects: 40
Study 18335728 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP plus Demetron LED (Kerr)
Number of subjects: 40
Study 18335728 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP plus LED/LASER (Bio-art)
Number of subjects: 40
Study 16572429 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission induction chemotherapy
Number of subjects: 77
Study 15272943 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensation for inconsistent behavior of a target by altering attributions of a fellow group member
Number of subjects: 6
Study 15272943 — intervention group
Group type: EXPERIMENTAL
Intervention: Compensation via a fellow group member for a target's inconsistent action
Number of subjects: 6
Study 15272943 — intervention group
Group type: EXPERIMENTAL
Intervention: Tests of capability and motivation assumptions of schema-maintenance through compensation
Number of subjects: 6
Study 10871578 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard parenteral nutrition (PN) containing conventional amounts of dextrose, amino acids, micronutrients, and lipid (120 kJ/d)
Number of subjects: 24
Study 10871578 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition containing only micronutrients and a small amount of lipid (12 kJ/d)
Number of subjects: 24
Study 9408513 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral angiotensin-converting-enzyme (ACE) inhibitors
Number of subjects: 0
Study 8257180 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEpo) administered subcutaneously twice a week
Number of subjects: 11
Study 8257180 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEpo)
Number of subjects: 11
Study 3954551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad lib smoking for two days
Number of subjects: 50
Study 3954551 — intervention group
Group type: EXPERIMENTAL
Intervention: First four days of abstinence from smoking
Number of subjects: 50
Study 3954551 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal discomfort
Number of subjects: 50
Study 31300978 — intervention group
Group type: EXPERIMENTAL
Intervention: Child sexual abuse severity
Number of subjects: 739
Study 31300978 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-silencing
Number of subjects: 739
Study 31300978 — intervention group
Group type: EXPERIMENTAL
Intervention: Divided self
Number of subjects: 739
Study 31300978 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-silencing strategies in romantic relationships
Number of subjects: 739
Study 29278339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Visual Analog Scale (VAS)
Number of subjects: 0
Study 29278339 — intervention group
Group type: EXPERIMENTAL
Intervention: Tender Joint Count in 28 joints (TJC28)
Number of subjects: 0
Study 29278339 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Visual Analog Scale (VAS) and Swollen Joint Count in 28 joints (SJC28)/Tender Joint Count in 28 joints (TJC28)
Number of subjects: 0
Study 27075705 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP/BPO (clindamycin 1%/benzoyl peroxide 5%) once daily gel
Number of subjects: 1020
Study 27075705 — intervention group
Group type: COMPARATOR
Intervention: CDP (clindamycin 1%) twice daily gel
Number of subjects: 1020
Study 25566615 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuntai Capsule (KC) combined with gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 100
Study 25566615 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonist (GnRH-a) alone
Number of subjects: 100
Study 23055493 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to low-irradiance intermittent green light (543 nm; 0.1-4 Hz) for 30 min
Number of subjects: 25
Study 23055493 — intervention group
Group type: COMPARATOR
Intervention: Continuous low-irradiance light exposure
Number of subjects: 25
Study 23055493 — intervention group
Group type: COMPARATOR
Intervention: Absence of rod-cone function
Number of subjects: 25
Study 20716302 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg)
Number of subjects: 31
Study 20716302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 17978058 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine/pyrimethamine (As + SP)
Number of subjects: 212
Study 17978058 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfamethoxypyrazine/pyrimethamine (As + SMP)
Number of subjects: 212
Study 15890352 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving the standard comparison tone before the target tone
Number of subjects: 4
Study 15890352 — intervention group
Group type: EXPERIMENTAL
Intervention: Using three target comparison tone pairs
Number of subjects: 4
Study 15890352 — intervention group
Group type: COMPARATOR
Intervention: Two-interval, forced-choice procedure
Number of subjects: 4
Study 12236457 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention (RP)
Number of subjects: 132
Study 12236457 — intervention group
Group type: COMPARATOR
Intervention: Standard 12-step focused group continuing care
Number of subjects: 132
Study 12236457 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse prevention (RP) with current depressive disorder at baseline
Number of subjects: 132
Study 9840564 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose intramuscular methotrexate (1 mg/kg)
Number of subjects: 75
Study 9840564 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic salpingostomy
Number of subjects: 75
Study 7985624 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported energy intake calculated from 3-day food records
Number of subjects: 269
Study 7985624 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 269
Study 7985624 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 269
Study 7985624 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 269
Study 2687467 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrugated silastic drain (Portex) placed next to the colonic anastomosis
Number of subjects: 106
Study 2687467 — intervention group
Group type: COMPARATOR
Intervention: No drain
Number of subjects: 106
Study 30670529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibiotalocalcaneal (TTC) nailing
Number of subjects: 110
Study 30670529 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 110
Study 28671626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia + Carbohydrate (200 mL/20 min maltodextrin)
Number of subjects: 15
Study 28671626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia + Glutamine (20 g/day) and 8% maltodextrin (200 mL/20 min)
Number of subjects: 15
Study 28671626 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia placebo
Number of subjects: 15
Study 26919755 — intervention group
Group type: COMPARATOR
Intervention: Control arm of the trial (specific intervention details not available)
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous pregnancy
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Early and consistent use of antenatal care
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Syphilis test
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal examination
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy danger signs advice
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Skilled birth attendant
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal labour duration
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestation period of at least 9 months
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal delivery
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood test for mothers
Number of subjects: 0
Study 26919755 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers aged less than 16 years and greater than 40 years
Number of subjects: 0
Study 24491065 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical fitness training (supported or unsupported treadmill training; cardiovascular active aerobic training; five times per week, over 4 weeks; each session 50 minutes; total of 20 sessions) in addition to standard rehabilitation treatment
Number of subjects: 215
Study 24491065 — intervention group
Group type: COMPARATOR
Intervention: Relaxation sessions (non-cardiovascular active; five times per week, over 4 weeks; each session 50 minutes) in addition to standard rehabilitation treatment
Number of subjects: 215
Study 22958784 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopy (ASK)
Number of subjects: 242
Study 22958784 — intervention group
Group type: EXPERIMENTAL
Intervention: Musculoskeletal ultrasound (MSUS)
Number of subjects: 242
Study 22958784 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 242
Study 22958784 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (ASK, MSUS, CON)
Number of subjects: 242
Study 22958784 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopy tutorial
Number of subjects: 242
Study 20670963 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Management Programme (DMP)
Number of subjects: 412
Study 20670963 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 412
Study 17327537 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver assessments of patient-centered, family-focused care (PCFFC)
Number of subjects: 210
Study 17327537 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective burden
Number of subjects: 210
Study 16355295 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg IM
Number of subjects: 40
Study 16355295 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac sodium 75 mg IM
Number of subjects: 40
Study 12029003 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 48
Study 12029003 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g/day)
Number of subjects: 48
Study 12029003 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin plus fish oil
Number of subjects: 48
Study 12029003 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 48
Study 9926052 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive sector services (PACE and PACT teams)
Number of subjects: 0
Study 9926052 — intervention group
Group type: COMPARATOR
Intervention: Standard sector services (generic community team)
Number of subjects: 0
Study 10512260 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 microg IT sufentanil
Number of subjects: 60
Study 10512260 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 microg IT sufentanil
Number of subjects: 60
Study 10512260 — intervention group
Group type: EXPERIMENTAL
Intervention: 17.5 microg IT sufentanil
Number of subjects: 60
Study 10512260 — intervention group
Group type: COMPARATOR
Intervention: 20 microg IT sufentanil
Number of subjects: 60
Study 1653313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:200,000 epinephrine-containing anesthetic solution
Number of subjects: 160
Study 1653313 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine hydrochloride solution
Number of subjects: 160
Study 6885206 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 10
Study 6885206 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen plus frusemide
Number of subjects: 10
Study 6885206 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 10
Study 6885206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30522143 — intervention group
Group type: EXPERIMENTAL
Intervention: 370 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30
Study 30522143 — intervention group
Group type: EXPERIMENTAL
Intervention: 740 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30
Study 30522143 — intervention group
Group type: EXPERIMENTAL
Intervention: 1110 mg of standardized Epimedium prenylflavonoid extract
Number of subjects: 30
Study 30522143 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Epimedium prenylflavonoid extract
Number of subjects: 30
Study 30522143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 27631895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pause procedure (1-min pause at the middle and end of the presentation)
Number of subjects: 214
Study 27631895 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture (control group)
Number of subjects: 214
Study 26660859 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 IU of intranasal oxytocin
Number of subjects: 13
Study 26660859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 26518980 — intervention group
Group type: EXPERIMENTAL
Intervention: SocketKAP(™) + Anorganic Bovine Bone Mineral (ABBM)
Number of subjects: 36
Study 26518980 — intervention group
Group type: EXPERIMENTAL
Intervention: SocketKAP(™) + SocketKAGE(™) + ABBM
Number of subjects: 36
Study 26518980 — intervention group
Group type: COMPARATOR
Intervention: Negative Control (Intact Socket)
Number of subjects: 36
Study 26518980 — intervention group
Group type: COMPARATOR
Intervention: Negative Control (Facial Dehiscence Socket)
Number of subjects: 36
Study 22204857 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10mg
Number of subjects: 54
Study 22204857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40mg
Number of subjects: 54
Study 21441615 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-treatment with valproate
Number of subjects: 24
Study 21441615 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of acridine (33 μM)
Number of subjects: 24
Study 21441615 — intervention group
Group type: EXPERIMENTAL
Intervention: Acridine
Number of subjects: 24
Study 18636543 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-volume preload (500 ml/171 kcal)
Number of subjects: 30